SIRT2 and metabolic dysfunction-associated steatotic liver disease: These findings suggest that OE-SIRT2 alleviates liver steatosis and inflammation during NAFLD progression induced by a high-fat and high-sugar diet, without affecting the fibrosis status of the liver within the given induction time.